Initiative involved 2,174 doctors across India and focused on early screening and awareness around regular blood pressure monitoring 

Mumbai, August 26^th, 2026: A large-scale blood pressure (BP) screening initiative conducted by Alembic Pharmaceuticals Limited, involving 40,468 patients and 2,174 doctors across India between May 7 and May 20, has earned the company recognition in the Asia Book of Records for achieving the record of “Maximum Patients Screened for Blood Pressure in a Fortnight.”

Undertaken to encourage early screening, improve awareness of hypertension-related risks and promote regular blood pressure monitoring, the screening drive formed part of Alembic Pharmaceuticals Limited’s broader focus on cardiovascular, renal and metabolic health. These themes were further explored at the company’s Triad Symposia, Mumbai, a platform that brought together cardiologists, nephrologists, endocrinologists and physicians to discuss the evolving approach to cardiovascular, renal and metabolic health. The symposia highlighted the interconnected nature of hypertension, diabetes and early kidney disease, and the importance of early screening, risk assessment and preventive care to address disease progression and reduce the risk of cardiovascular and chronic kidney disease.

Experts highlighted the need to look at the individual as a whole rather than treating each condition in isolation. They also spoke about seeing hypertension among younger Indians, including people in their 20s and 30s, with factors such as physical inactivity, smoking, alcohol consumption, dietary habits and stress adding to the risk. The concern is compounded by the fact that hypertension can remain undiagnosed, untreated, or uncontrolled in a majority of individuals, leading to heart- and kidney-related complications if not addressed through timely intervention.

The success of the screening drive and the broader discussions around proactive healthcare were supported by the active contribution of the company’s senior leadership team, including Mr. Kunal Mukhopadhaya, Senior Vice President – CV Business; Mr. Ashish Singh Chauhan, Vice President; Dr. Sanjay Jain, Vice President Medical Team ; Mrs. Ashvini Mundhada, Deputy General Manager; Mr. Vinod Bhat, AGM, along with the entire Alembic Specia Speciality Sales & Marketing Team.

The event concluded in the presence of leading doctors, including Hon’ble Dr. Ashok Kirpalani, Dr. B. C. Kalmath, Dr. Sandip Fulpagare, Dr. Chetan Shah, Dr. Gaurav Daga, Dr. Johann Verghese, Dr. Rohit Barnabas, Dr. Manjiri Karlekar, Dr. Vikas Bharati and Dr. Nitin Sonavane, along with 65 other doctors from across Mumbai. The initiative and Alembic Pharmaceuticals Limited’s patient-first approach received widespread appreciation from the medical fraternity.

The Asia Book of Records recognition marks a significant milestone for Alembic that reflects the larger purpose behind the screening initiative. The initiative aims to make important health checks more accessible, encourage people to monitor their health and help identify risks before they become more difficult to manage.

Prevalence of diabetes in women (18 years and above) in India in 2022 is 23.7%.¹ Studies estimate that approximately 8-10% of women in India have diabetes, though rates vary by region, age group, and urban versus rural setting. Urban areas often have a higher prevalence due to lifestyle factors, while rural areas show increasing rates as well.²

The awareness campaign, unveiled at the prestigious 52^nd Annual Conference of Research Society for the Study of Diabetes in India (RSSDI) in Delhi, introduces a comprehensive “9 Steps” approach for diabetes management and prevention in women. This evidence-based framework, developed in collaboration with over 20,000 healthcare professionals, addresses the unique challenges faced by women with diabetes.

• Step 1 – 1 resistance exercise in a day
• Step 2 – 2 hours of gap between dinner and bedtime
• Step 3 – 3 to 2 meals per day
• Step 4 – 4 rest breaks or mini breaks
• Step 5 – 5 servings of fresh fruits and vegetables
• Step 6 – 6 minutes of meditation
• Step 7 – 7 hours of sleep
• Step 8 – 8 glasses of water
• Step 9 – 9,000 steps a day

A ‘9-Steps’ poster to reinforce the importance of effective lifestyle modification and management of diabetes was released during the RSSDI meeting in Delhi on November 15, 2024. In addition, the official Asia Book of Records ceremony recognizing this noteworthy accomplishment took place during this occasion.

The campaign, part of Emcure’s “SAKHI” initiative, demonstrates the company’s commitment to improving women’s health through innovative approaches to disease management and prevention.